HispanicHedge

Lipocine $LPCN 4th Submission Run-up

NASDAQ:LPCN   Lipocine Inc.
Lipocine Inc $LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.

Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
www.prnewswire.com/n...issed-301103629.html

I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。